© Copyright Our Wall
Roots Analysis has done
a detailed study on “Global Antibiotics Market 2023–2035””
report to its list of covering
key aspects of the industry’s evolution and identifying potential future growth
opportunities.
Key Market Insights
§
Presently,
around 60 players worldwide are engaged in the development of novel antibiotics
to treat a wide range of clinical conditions; majority of such players are
headquartered in North America.
§
Close
to 70% of the antibiotics have been approved for use in North America, specifically
the US; majority of these therapies are quinolones approved for the prevention
/ treatment of pulmonary infections.
§
Currently,
150 clinical-stage antibiotics are being evaluated across different stages of
preclinical / clinical development, either as monotherapies or in combination
with other drugs to target various types of bacteria.
§
Given
the rising prevalence of bacterial infections, over 50 stakeholders are focused
on the development and evaluation of antibiotics targeting a wide range of gram
positive and negative bacterial strains.
§
The
growing interest in this domain is evident from the rise in partnership
activity; in fact, the maximum number of collaborations related to antibiotics
have been inked in the last three years.
§
Since
2010, over 1,720 clinical trials have been registered to evaluate the safety
and efficacy of various antibiotics; majority of these studies have been
conducted across various sites in the US.
§
Several
researchers from renowned universities, currently involved in evaluating
efficacy and safety of antibiotics, have emerged as key opinion leaders (KOL);
of these, majority of the KOLs are Doctors of Medicine.
§
The global antibiotics marketis
anticipated to grow at a steady pace in coming decade; majority of the share is
captured by drugs targeting urinary tract infections.
§
The opportunity associated with the global antibiotic marketis
likely to be well distributed across various types of therapies, routes of
administration and key geographical regions.
§
Informed
estimates of the existing global antibiotics
market sizeand the
future opportunity, over the next decade. Based on multiple parameters, such as
drug class, mechanism of action, nature of source, target disease indication,
type of therapy, routes of administration and key geographical regions. We have
provided informed estimates on the evolution of the market for the period
2020-2030.
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
1. EXECUTIVE
SUMMARY
2. INTRODUCTION
2.1. Overview of
Antibiotics
2.2. Characteristics
of an Ideal Antibiotic
2.3. Advantages of
Antibiotics
2.4. Classification
of Antibiotics
2.5. History of
Antibiotics
2.6. Developments
in Antibiotics during the Discovery Void
2.7. Mechanism of
Action of Antibiotics
2.8. Challenges
associated with the use of Antibiotics
2.9. Future
Perspectives
3. MARKET LANDSCAPE:
APPROVED ANTIBIOTIC GENERICS
3.1. Approved
Antibiotic Generics: Overall Market Landscape
3.2. Approved
Antibiotic Generics: Developer Landscape
4. MARKET
LANDSCAPE: APPROVED ANTIBIOTIC BRANDS
4.1. Approved
Antibiotic Brands: Overall Market Landscape
4.2. Approved
Antibiotic Brands: Developer Landscape
5. MARKET
LANDSCAPE: CLINICAL-STAGE ANTIBIOTICS
5.1. Clinical-stage
Antibiotics: Overall Market Landscape
5.2. Clinical-stage
Antibiotics: Developer Landscape
6. COMPANY
PROFILES
6.1. Bristol-Myers
Squibb
6.1.1. Company
Overview
6.1.2. Key Executives
6.1.3. Financial
Information
6.1.4. Product
Portfolio
6.1.5. Recent
Developments
6.1.6. Key Strategies
6.1.7. Key Focus Areas
6.1.8. Expert Opinion
6.3. GlaxoSmithKline
6.4. Melinta
Therapeutics
6.5. Merck
6.6. Pfizer
6.7. Concluding
Remarks
7. PARTNERSHIPS
AND COLLABORATIONS ANALYSIS
7.1. Partnership
Models
7.2. Antibiotics:
List of Partnerships and Collaborations
8. CLINICAL
TRIAL ANALYSIS
8.1. Analysis
Methodology and Key Parameters
8.2. Antibiotics:
Clinical Trial Analysis
9. KEY OPINION
LEADERS
9.1. Assumptions
and Key Parameters
9.2. Methodology
9.3. Antibiotics:
Key Opinion Leaders (KOLs)
10. KEY TRENDS IN
ANTIBIOTICS INDUSTRY
10.1. Impact of
COVID-19 on Antibiotics Industry
10.2. Key Trends in
Antibiotics Domain Post-COVID-19
10.3. Outsourcing
Trends
10.4 Drug Pricing
Analysis by Drug Class
11. APPROVED
ANTIBIOTICS: SUCCESS PROTOCOL ANALYSIS
11.1. Chapter
Overview
11.2. Methodology and
Scoring Criteria
11.3. Success
Protocol Analysis of Recently Approved Antibiotic Brands
11.4. Concluding
Remarks
12. MARKET
FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter
Overview
12.2. Methodology and
Key Parameters
12.3. Global Market
opportunity, 2023-2035 (USD Billion)
13. APPENDIX I:
TABULATED DATA
14. APPENDIX II:
LIST OF COMPANIES AND ORGANIZATIONS
To
view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/global-antibiotics-market.html
Learn
from experts: do you know about these
emerging industry trends?
Patient
Recruitment – Key Determinant of Successful Clinical Trials
Exploring AI-based
Digital Pathology
Learn from our recently published
whitepaper: -
Next
Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the
pharma / biotech market research. Having worked with over 750 clients
worldwide, including Fortune 500 companies, start-ups, academia, venture
capitalists and strategic investors for more than a decade, we offer a highly
analytical / data-driven perspective to a network of over 450,000 senior
industry stakeholders looking for credible market insights.
Learn more about Roots
Analysis consulting services:
Roots Analysis Consulting - the
preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
The Wall